Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03206216 · ClinicalTrials.gov registry record · NA
Feasibility Study of New Method of Diagnostic and Prediction of Painful CIPN
A NA study, sponsored by Stanford University.
- Terminated
- Registry status
- NA
- Development phase
- 1
- Enrollment target
NCT03206216: Clinical Trial NA study, sponsored by Stanford University.
NCT03206216 is a NA study that was terminated before completion, run by Stanford University. The registered enrollment target is 1 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03206216, a NA study, was terminated before completion, sponsored by Stanford University.
- TERMINATED
- Registry status
- NA
- Development phase
- 1 participants
- Enrollment target
Study Summary
This clinical trial studies how well Diode laser fiber type Selective Stimulator (DLss) works in predicting pain development in patients with ovarian cancer who are receiving chemotherapy. Stimulating of the pain nerve fibers in the skin with laser light stimulation may help to predict whether a patient will develop painful peripheral neuropathy, correlate with the severity of neuropathy during and after chemotherapy treatment, and may help to explain the mechanisms of chemotherapy-induced neuropathic pain (CIPN).
Primary Outcome
The "A-delta:C pain threshold ratio" is calculated based on the A-delta-fiber and C-fiber pain thresholds. The outcome was the difference in the A-delta:C pain ratio between the 9-week assessment and the 21-week assessment, to be reported as the mean with standard deviation for participant with painful CIPN (Group A) or painless CIPN (Group B).
Interventions
- DIAGNOSTIC_TEST Diode Laser fiber type Selective Stimulator (DLss)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2017-08-04 |
| Est. Completion | 2017-10-30 |
| Phase | NA |
Why NCT03206216 stopped before completion
NCT03206216 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 1 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Diode Laser fiber type Selective Stimulator (DLss) is the first listed.
NCT03206216 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03206216 about?
NCT03206216 is a clinical study titled "Feasibility Study of New Method of Diagnostic and Prediction of Painful CIPN". This clinical trial studies how well Diode laser fiber type Selective Stimulator (DLss) works in predicting pain development in patients with ovarian cancer who are receiving chemotherapy. Stimulating of the pain nerve fibers in the skin with laser light stimulation may help to predict whether a pat...
What is the current status of trial NCT03206216?
This trial is currently terminated. It is a NA study. The enrollment target is 1 participants. The study started on 2017-08-04. Estimated completion is 2017-10-30.
What interventions are being tested in trial NCT03206216?
The interventions under investigation include: Diode Laser fiber type Selective Stimulator (DLss) (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03206216?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03206216's enrollment target sits among peer trials
1 2001st of 2000 the lowest of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI